new guidelines for treating latent tuberculosis

July 2000

The CDC just released new guidelines for treating latent tuberculosis.

There are changes in the length of isoniazid therapy...plus some shorter rifampin-based regimens to increase compliance and avoid the risk of hepatotoxicity or neuropathy with isoniazid.

Isoniazid...300 mg/day for 6 to 9 months. Give INH for the full 9 months to children...or patients with HIV or previous TB.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

more aggressive treatment of hypertension in patients with diabetes
Allergic Reactions which drugs might cause problems in patients with sulfa allergies
Cardiology starting statins EARLIER after an MI
Cardiology TNKase (T-N-Kase, tenecteplase), a new thrombolytic for acute MIs
new guidelines for treating asthma during pregnancy
Women's Health lengthening oral contraceptive cycles
Women's Health low-dose oral contraceptives to women right up to menopause
Women's Health Activella, a new combo HRT tablet for postmenopausal women
Infectious Diseases new guidelines for treating latent tuberculosis
Cynara-SL, a new dietary supplement made from artichokes
Zyprexa (olanzapine) for treating acute mania in patients with bipolar disorder
Provigil (modafinil) helps reduce fatigue in patients with multiple sclerosis
Stroke aspirin should be started sooner for most stroke patients
Practice splendid review of our Natural Medicines Comprehensive Database

new guidelines for treating latent tuberculosis

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents